Serial Interval of Novel Coronavirus Infections PDF
Serial Interval of Novel Coronavirus Infections PDF
PII: S1201-9712(20)30119-3
DOI: https://doi.org/10.1016/j.ijid.2020.02.060
Reference: IJID 4006
Please cite this article as: Nishiura H, Linton NM, Akhmetzhanov AR, Serial interval of novel
coronavirus (COVID-19) infections, International Journal of Infectious Diseases (2020),
doi: https://doi.org/10.1016/j.ijid.2020.02.060
This is a PDF file of an article that has undergone enhancements after acceptance, such as
the addition of a cover page and metadata, and formatting for readability, but it is not yet the
definitive version of record. This version will undergo additional copyediting, typesetting and
review before it is published in its final form, but we are providing this version to give early
visibility of the article. Please note that, during the production process, errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal
pertain.
Authors:
Affiliations:
f
oo
1
Graduate School of Medicine, Hokkaido University, Kia 15 Jo Nishi 7 Chome,
pr
Agency, Honcho 4-1-8, Kawaguchi, Saitama, 332-0012 Japan;
e-
Correspondence to: H. Nishiura, Graduate School of Medicine, Hokkaido
Pr
Article type:
n
Original article
ur
Jo
Highlights
-1-
The median serial interval is shorter than the median incubation period,
A short serial interval makes it difficult to trace contacts due to the rapid
Abstract
f
from information on 28 infector-infectee pairs.
oo
Methods: We collected dates of illness onset for primary cases (infectors) and
pr
investigation reports. We subjectively ranked the credibility of the data and
e-
performed analyses on both the full dataset (n=28) and a subset of pairs with
Results: Accounting for right truncation and analyzing all pairs, we estimated
al
the median serial interval at 4.0 days (95% credible interval [CrI]: 3.1, 4.9).
Limiting our data to only the most certain pairs, the median serial interval was
n
secondary transmission may occur prior to illness onset. The COVID-19 serial
interval is also shorter than the serial interval of severe acute respiratory
syndrome (SARS), indicating that calculations made using the SARS serial
-2-
Keywords: coronavirus; outbreak; illness onset; generation time; statistical
Introduction
China in late 2019 has rapidly grown and cases have been reported worldwide.
f
oo
primary case (infector) to illness onset in a secondary case (infectee)—is needed
pr
[1]. Estimates of the serial interval can only be obtained by linking dates of onset
for infector-infectee pairs, and these links are not easily established. A recently
e-
published epidemiological study used contact tracing data from cases reported in
Hubei Province early in the epidemic to estimate the mean serial interval at 7.5
Pr
days [2], which is consistent with the 8.4-day mean serial interval reported for
data [3]. However, there were only six infector-infectee pairs in this dataset, and
n
sampling bias may have been introduced to the variance and mean. To further
ur
publicly shared infector-infectee pairs and calculated the serial interval from
Jo
these data.
and quoted from official reports of outbreak investigations to obtain our dataset.
-3-
The date of illness onset was defined as the date on which a symptom relevant to
pairs into “certain” and “probable,” where the former was used for pairs and
dates of illness onset were clearly defined in an academic article and the latter
was applied to pairs and dates of illness onset that were clearly defined but
f
oo
analysis, and the verification of illness onset date was ensured following an
obtained for certain and probable pairs combined (n=28) as well as for the certain
𝐸𝑅.𝑖 𝑆𝑅.𝑖
𝐿(𝛩𝑔 ; 𝑫) = ∏ ∫ ∫ 𝑔(𝑒)𝑓(𝑠 − 𝑒)d𝑠d𝑒 ,
al
(1)
𝑖 𝐸𝐿.𝑖 𝑆𝐿.𝑖
where i represents the identity of each pair, (ER,i, EL,i) is the interval for symptom
n
onset of the infector and (SR,i, SL,i) is the interval for symptom onset of the
ur
infectee. Intervals are allowed for illness onset event so that the serial interval
Jo
can be inferred even when we do not have exact dates of illness onset for infetor-
infectee pairs. Here, g(.) is the probability density function (p.d.f.) of exposure
dependence in the frequency of illness onset among primary cases. f(.) is the
-4-
distributions—lognormal, gamma, and Weibull. We sampled the posterior
(http://github.com/aakhmetz/nCoVSerialInteval2020).
As the epidemic will continue to grow beyond our data collection cutoff
underestimates the serial interval as sampling during the early stage of the
f
oo
model. The alternative p.d.f. that accounts for right truncation during the
𝑓′(𝑠 − 𝑒, 𝑒) =
𝑓(𝑠 − 𝑒)
𝑇−𝑒 𝑟exp(−𝑟𝑢)
pr
∫0 1 − exp(−𝑟𝑢) 𝐹(𝑇 − 𝑒 − 𝑢)du
(2)
e-
where r is the exponential growth rate estimated at 0.14 [7] and T is the latest
Pr
time of observation (12 February 2020). We account for the exponential growth
rate of cases, because recently infected individuals are more likely to be sampled
information criterion (WAIC) was used to compare between distributions and the
n
model with the minimal WAIC value was selected as the best-fit model for each
ur
Results
Jo
right truncation and analyzing all pairs, the model using the lognormal
-5-
significant differences from other models were identified. The median serial
interval was estimated at 4.0 days (95% credible interval [CrI]: 3.1, 4.9) while
the mean and standard deviation (SD) of the serial interval were estimated at 4.7
days (95% CrI: 3.7, 6.0) and 2.9 days (95% CrI: 1.9, 4.9), respectively. Without
truncation, the model using the lognormal distribution was also the best-fit model
(WAIC=128.0) with the median serial interval was estimated at 3.9 days (95%
f
oo
interval of the best-fit Weibull distribution model was estimated at 4.6 days (95%
CI: 3.5, 5.9) with a mean and SD of 4.8 days (95% CrI: 3.8, 6.1) and 2.3 days
pr
(95% CrI: 1.6, 3.5), respectively. Without truncation, the best-fit model used the
lognormal distribution and estimated the median serial interval at 4.1 days (95%
e-
CrI: 3.2, 5.0). Figure 1 shows the best-fit distributions overlaid with a published
Discussion
al
Our estimate of the median serial interval as 4.0 days indicates that
cases to the next. The shorter serial interval compared to SARS implies that
ur
contact tracing methods must compete against the rapid replacement of case
Jo
generations, and the number of contacts may soon exceed what available
healthcare and public health workers are able to handle. The difference between
these distributions suggests that using serial intervals estimates from SARS data
-6-
More importantly, the estimated median serial interval is shorter than the
[2,8]. As illustrated in Figure 2, when the serial interval is shorter than the
symptomatic cases, as by the time contacts are traced they may have already
f
oo
become infectious themselves and generated secondary cases [9]. It is possible
that serial intervals were shortened due to case isolation, especially outside of
China, but even the subset of data in China alone can indicate that the mean is
the serial interval. Considering the overall mild nature of the infection [10] it is
Pr
potential bias we are unable to account for. However, the present study addresses
n
the issue of data quality of the reported pairs in two ways. First, our data include
ur
Germany [4] where it was later found that the primary case was already
Jo
data and comparing analyses including and excluding less certain (but
nonetheless highly probable) pairs allowed us to determine that our results using
-7-
all pairs (and therefore a greater sample size) did not differ significantly from the
4.0 days, which is close to or shorter than the disease’s median incubation period
transmissions are occurring. Thus, containment via case isolation alone is likely
to be very challenging.
f
oo
Funding source
H.N. received funding support from Japan Agency for Medical Research and
pr
Development [grant number: JP18fk0108050] the Japan Society for the
e-
Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI
19H01074, and the Japan Science and Technology Agency (JST) Core Research
Education, Culture, Sports, Science and Technology, Japan. The funders had no
n
Ethical approval
This study was based on publicly available data and did not require ethical
approval.
-8-
Conflict of interest
Declaration of interests
☒ The authors declare that they have no known competing financial interests or
personal relationships that could have appeared to influence the work reported in
this paper.
f
oo
pr
e-
Pr
n al
ur
Jo
-9-
References
J Epidemiol 2003;158:1039-1047.
f
Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi
oo
G, Lam TTY, Wu JTK, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z.
pr
Infected Pneumonia. N Engl J Med. 2020; in press. doi:
10.1056/NEJMoa2001316
e-
3. Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, Gopalakrishna
2003;300(5627):1966-70.
al
press. doi:10.1056/NEJMc2001468.
Jo
- 10 -
7. Jung S, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B,
medRxiv. http://dx.doi.org/10.1101/2020.01.26.20018754
f
9. Fraser C, Riley S, Anderson RM, Ferguson NM. Factors that make an
oo
infectious disease outbreak controllable. Proceedings of the National
6151.
pr
10. Nishiura H, Kobayashi T, Yang Y, Hayashi K, Miyama T, Kinoshita R,
e-
Linton NM, Jung S, Yuan B, Suzuki A, Akhmetzhanov AR. The rate of
press. doi:10.3390/jcm9020419.
n al
ur
Jo
- 11 -
Figure Legends
f
oo
Figure 1. Serial interval of novel coronavirus (COVID-19) infections.
The solid line shows the estimated serial interval distribution of COVID-19
pr
infections using the best-fit lognormal distribution with right truncation. A
e-
distribution based on a published estimate of the serial interval for severe acute
Figure 2. The relationship between the incubation period and serial interval.
- 12 -
If the transmission takes place during the symptomatic period of the primary
case, the serial interval is longer than the incubation period. However, this
Furthermore, it is possible that the secondary case may even experience illness
f
oo
pr
e-
Pr
n al
ur
Jo
- 13 -